BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 25440623)

  • 1. The effect of intraoperative 6% balanced hydroxyethyl starch (130/0.4) during cardiac surgery on transfusion requirements.
    Hans GA; Ledoux D; Roediger L; Hubert MB; Koch JN; Senard M
    J Cardiothorac Vasc Anesth; 2015 Apr; 29(2):328-32. PubMed ID: 25440623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of 6 % hydroxyethyl starch (HES) 130/0.4 on the correlation between standard laboratory tests and thromboelastography (TEG®) after cardiopulmonary bypass.
    Hans GA; Hartstein G; Roediger L; Hubert B; Peters P; Senard M
    Thromb Res; 2015 May; 135(5):984-9. PubMed ID: 25769493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydroxyethyl Starch 130/0.4 and the Risk of Acute Kidney Injury After Cardiopulmonary Bypass: A Single-Center Retrospective Study.
    Lagny MG; Roediger L; Koch JN; Dubois F; Senard M; Donneau AF; Hubert MB; Hans GA
    J Cardiothorac Vasc Anesth; 2016 Aug; 30(4):869-75. PubMed ID: 26774199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of 6% hydroxyethyl starch 130/0.4 (Voluven) for perioperative volume replacement in children undergoing cardiac surgery: a propensity-matched analysis.
    Van der Linden P; Dumoulin M; Van Lerberghe C; Torres CS; Willems A; Faraoni D
    Crit Care; 2015 Mar; 19(1):87. PubMed ID: 25886765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Balanced 10% hydroxyethyl starch compared with balanced 6% hydroxyethyl starch and balanced crystalloid using a goal-directed hemodynamic algorithm in pancreatic surgery: A randomized clinical trial.
    Werner J; Hunsicker O; Schneider A; Stein H; von Heymann C; Freitag A; Feldheiser A; Wernecke KD; Spies C
    Medicine (Baltimore); 2018 Apr; 97(17):e0579. PubMed ID: 29703051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Colloids in Cardiac Surgery-Friend or Foe?
    Ryhammer PK; Tang M; Hoffmann-Petersen J; Leonaviciute D; Greisen J; Storebjerg Gissel M; Jakobsen CJ
    J Cardiothorac Vasc Anesth; 2017 Oct; 31(5):1639-1648. PubMed ID: 28372955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Volume replacement therapy during hip arthroplasty using hydroxyethyl starch (130/0.4) compared to lactated Ringer decreases allogeneic blood transfusion and postoperative infection.
    Hamaji A; Hajjar L; Caiero M; Almeida J; Nakamura RE; Osawa EA; Fukushima J; Galas FR; Auler JO
    Braz J Anesthesiol; 2013 Jan; 63(1):27-35. PubMed ID: 24565088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the effects of albumin 5%, hydroxyethyl starch 130/0.4 6%, and Ringer's lactate on blood loss and coagulation after cardiac surgery.
    Skhirtladze K; Base EM; Lassnigg A; Kaider A; Linke S; Dworschak M; Hiesmayr MJ
    Br J Anaesth; 2014 Feb; 112(2):255-64. PubMed ID: 24169821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Volume replacement therapy during hip arthroplasty using hydroxyethyl starch (130/0.4) compared to lactated Ringer decreases allogeneic blood transfusion and postoperative infection.
    Hamaji A; Hajjar L; Caiero M; Almeida J; Nakamura RE; Osawa EA; Fukushima J; Galas FR; Auler Junior JO
    Braz J Anesthesiol; 2013; 63(1):27-35. PubMed ID: 23438799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postoperative Acute Kidney Injury and Blood Product Transfusion After Synthetic Colloid Use During Cardiac Surgery.
    Tobey R; Cheng H; Gao M; Li Z; Young JN; Boyd WD; Ji F; Liu H
    J Cardiothorac Vasc Anesth; 2017 Jun; 31(3):853-862. PubMed ID: 28302346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New 6% hydroxyethyl starch 130/0.4 does not increase blood loss during major abdominal surgery - a randomized, controlled trial.
    Hung MH; Zou C; Lin FS; Lin CJ; Chan KC; Chen Y
    J Formos Med Assoc; 2014 Jul; 113(7):429-35. PubMed ID: 24961184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perioperative fluid therapy with tetrastarch and gelatin in cardiac surgery--a prospective sequential analysis*.
    Bayer O; Schwarzkopf D; Doenst T; Cook D; Kabisch B; Schelenz C; Bauer M; Riedemann NC; Sakr Y; Kohl M; Reinhart K; Hartog CS
    Crit Care Med; 2013 Nov; 41(11):2532-42. PubMed ID: 23978813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of a waxy maize and a potato starch-based balanced hydroxyethyl starch for priming in patients undergoing coronary artery bypass grafting.
    Sethi BS; Chauhan S; Bisoi AK; Kapoor PM; Kiran U; Rajput RS
    J Cardiothorac Vasc Anesth; 2014 Jun; 28(3):690-7. PubMed ID: 24144628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of hydroxyethyl starches in cardiac surgery: a meta-analysis.
    Jacob M; Fellahi JL; Chappell D; Kurz A
    Crit Care; 2014 Dec; 18(6):656. PubMed ID: 25475406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiopulmonary bypass priming using a high dose of a balanced hydroxyethyl starch versus an albumin-based priming strategy.
    Boldt J; Suttner S; Brosch C; Lehmann A; Röhm K; Mengistu A
    Anesth Analg; 2009 Dec; 109(6):1752-62. PubMed ID: 19923501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluid Management in Cardiac Surgery: Results of a Survey in European Cardiac Anesthesia Departments.
    Protsyk V; Rasmussen BS; Guarracino F; Erb J; Turton E; Ender J
    J Cardiothorac Vasc Anesth; 2017 Oct; 31(5):1624-1629. PubMed ID: 28778778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Albumin utilization in cardiac surgery after transition to hydroxyethyl starch 130/0.4.
    Romerill DB; Toyoda AY; Brodeur BE; Moellentin D
    J Pharm Pract; 2012 Dec; 25(6):606-10. PubMed ID: 22797837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Large-dose hydroxyethyl starch 130/0.4 does not increase blood loss and transfusion requirements in coronary artery bypass surgery compared with hydroxyethyl starch 200/0.5 at recommended doses.
    Kasper SM; Meinert P; Kampe S; Görg C; Geisen C; Mehlhorn U; Diefenbach C
    Anesthesiology; 2003 Jul; 99(1):42-7. PubMed ID: 12826840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Volume replacement with a balanced hydroxyethyl starch (HES) preparation in cardiac surgery patients.
    Boldt J; Mayer J; Brosch C; Lehmann A; Mengistu A
    J Cardiothorac Vasc Anesth; 2010 Jun; 24(3):399-407. PubMed ID: 20510247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The intraoperative therapeutic equivalence of balanced vs saline-based 6% hydroxyethyl starch 130/0.4 and their influence on perioperative acid-base status and renal functions.
    Helmy A; Mukhtar A; Ahmed A; Sief NE; Hussein A
    J Clin Anesth; 2016 Aug; 32():267-73. PubMed ID: 27290988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.